Vitamin B6
The only vitamin in ProleevaMax — the essential cofactor that makes Pathway 4's neurotransmitter ingredients work. Mechanism, evidence, and honest safety notes.
A note from Cristina Lanzieri.
When I went through the literature on Vitamin B6, the strongest signal wasn't about B6 itself — it was about what stops working when B6 is insufficient. ProleevaMax's Pathway 4 includes 5-HTP, GABA, and choline. Each of those ingredients has its own mechanism and its own evidence base. But B6 is the enzyme cofactor that most of Pathway 4 depends on. If your B6 status is suboptimal, the precursor-to-neurotransmitter conversions those ingredients support become less efficient. I want to explain why that matters, what the literature actually shows, and — because this is one of the better-characterized vitamins in the supplement safety literature — where the real ceiling is, honestly. That's why it belongs in ProleevaMax.
What it is
Vitamin B6 is a water-soluble B vitamin that exists in several interconvertible forms. The form in ProleevaMax is pyridoxine hydrochloride (pyridoxine HCl) — the standard supplemental form, chosen for its stability and bioavailability. Once absorbed, the body converts pyridoxine to pyridoxal 5'-phosphate (PLP) via a riboflavin-dependent enzymatic step. PLP is the biologically active coenzyme; pyridoxine HCl is the delivery form. This conversion step matters: it's why B2 (riboflavin) sufficiency is a quiet prerequisite for optimal B6 activity, and it's part of why studying "B6 status" in clinical populations is more nuanced than measuring a single blood marker1.
How it works
PLP participates as a coenzyme in more than 100 enzymatic reactions in the human body — the largest functional footprint of any single coenzyme in amino acid metabolism1. The reactions most relevant to Pathway 4 fall into three clusters.
Neurotransmitter synthesis. PLP is a required cofactor for the decarboxylation of 5-hydroxytryptophan (5-HTP) to serotonin, for the conversion of tyrosine to dopamine (via DOPA decarboxylase), and for the conversion of glutamate to gamma-aminobutyric acid (GABA) via glutamate decarboxylase. This last conversion is the load-bearing mechanism for why B6 is the enabling ingredient for the rest of Pathway 4: GABA is already present in ProleevaMax as a direct precursor, but the body's endogenous GABA synthesis — and the conversion efficiency of glutamate — depends on PLP availability2. The same applies to 5-HTP: its clinical trial record assumes adequate B6 for the final conversion step. A 2020 paper in the Journal of Cell and Molecular Medicine showed that B6 deficiency or suboptimal status reduces the efficacy of neurotransmitter-precursor supplementation by impairing these decarboxylase enzymes, not the precursor supply2.
Homocysteine metabolism. PLP is a cofactor in the transsulfuration pathway — working alongside folate and B12 in the one-carbon cycle to process homocysteine. Elevated homocysteine is a known marker of systemic inflammatory load. A 2018 review in Advances in Food and Nutrition Research documented that adequate B6 status is associated with lower circulating inflammatory markers including C-reactive protein (CRP), and that inflammatory load itself depresses B6 status — a bidirectional relationship that explains why chronically inflamed individuals often show suboptimal B6 even with adequate dietary intake3.
Inflammatory modulation. B6 status has a documented relationship with systemic inflammation beyond homocysteine. The same 2018 review found that B6 deficiency amplifies NF-κB-mediated inflammatory signaling — the same upstream pathway that curcumin (Pathway 1) modulates — and that B6 repletion supports a return toward baseline inflammatory gene expression. This is not a dominant anti-inflammatory mechanism; it's a permissive one. B6 doesn't quiet inflammation directly. It removes a bottleneck that would otherwise impair the other ingredients doing that work.*
The evidence
The strongest direct clinical evidence for B6 in a musculoskeletal inflammatory context is Ghavidel-Parsa and colleagues (2022), published in BMC Musculoskeletal Disorders — a randomized controlled trial in fibromyalgia patients that found B6 supplementation produced statistically significant improvements in pain and fatigue scores compared to placebo4. Fibromyalgia involves a complex central sensitization picture, and the authors attributed the benefit primarily to B6's role in neurotransmitter synthesis and central pain modulation — the same mechanistic logic that places B6 in Pathway 4.
The inflammation-and-B6-status literature is broader and consistent. The bidirectional CRP-B6 association has been replicated across large observational cohorts, including the National Health and Nutrition Examination Survey (NHANES) data. Chronically inflamed individuals are systematically more likely to show marginal B6 status — meaning that B6 supplementation in a ProleevaMax user is addressing a plausible real gap, not a theoretical one3.
Vitamin B6 in Health and Disease
Stach K, Stach W, Augoff K — Nutrients · 2021
The Role of Nutrients in Protecting Mitochondrial Function and Neurotransmitter Signaling
Du J, Zhu M, Bao H, et al — J Cell Mol Med · 2020
The Emerging Role of Vitamin B6 in Inflammation and Carcinogenesis
Bird RP — Adv Food Nutr Res · 2018
The Iceberg Nature of Fibromyalgia Burden: the Clinical and Economic Aspects
Ghavidel-Parsa B, et al — BMC Musculoskelet Disord · 2015
Sensory Neuropathy from Pyridoxine Abuse
Schaumburg H, Kaplan J, Windebank A, et al — N Engl J Med · 1983
Dosage
Clinical trials in inflammatory and neurological contexts typically use 25-100 mg/day. Standard multivitamins provide 1-2 mg/day (the RDA is 1.3-1.7 mg/day for adults). ProleevaMax uses a supplement-formulation dose within the studied range — consistent with multi-ingredient context where B6 is a cofactor enabler, not a standalone intervention. Consult your physician before starting any B-vitamin regimen, particularly if you take medications that interact with B6 metabolism.
Safety & interactions
B6 is well-tolerated for most adults at supplement doses in the standard studied range. There is, however, a documented safety ceiling that I think is worth stating clearly and precisely.
High-dose B6 has been associated with sensory peripheral neuropathy — numbness, tingling, and impaired proprioception. The landmark report is Schaumburg and colleagues (1983) in the New England Journal of Medicine, which documented sensory neuropathy in patients consuming chronic high doses, primarily above 200 mg/day5. Subsequent literature has largely confirmed this signal: risk is dose-and-duration related, predominantly reported at chronic doses above 200 mg/day, and in the more extreme historical cases at 1 g/day or more. The neuropathy is mostly reversible on discontinuation. Standard supplement formulations — including ProleevaMax — operate well below this ceiling; this is a concern for chronic megadosing, not for daily supplement use at typical doses. But honesty requires stating the ceiling exists, not just that "B6 is safe."
Other interactions worth noting:
- Levodopa (Parkinson's medications) — B6 accelerates the peripheral metabolism of levodopa, reducing its effectiveness in crossing the blood-brain barrier. If you take levodopa for Parkinson's disease, do not add B6 supplementation without your neurologist's guidance.
- Phenytoin and phenobarbital — B6 may modestly reduce blood levels of these anticonvulsants. Monitor with your physician if you are on either.
Pregnancy: food-level B6 is widely consumed safely; B6 supplementation is in fact commonly prescribed for pregnancy-related nausea at physician-directed doses. High-dose supplemental B6 in pregnancy should remain under medical supervision.
In ProleevaMax
Vitamin B6 is the sole vitamin in ProleevaMax, and its role is explicitly that of a cofactor enabler for Pathway 4 — Nervous System Resilience. The other Pathway 4 ingredients (5-HTP, GABA, choline, L-serine) are present because chronic inflammatory load consistently disrupts neurotransmitter balance and sleep architecture. B6 is the ingredient that makes those conversions run efficiently. Without adequate PLP, 5-HTP cannot fully convert to serotonin and glutamate cannot fully convert to GABA — the co-formulation logic is that the precursors need their cofactor. ProleevaMax includes pyridoxine HCl at a dose intended to support cofactor availability across the full Pathway 4 cluster.*
Frequently asked questions
B6 is one of the better-characterized ingredients in the formula from a literature standpoint. The neurotransmitter cofactor mechanism is well-mapped, the inflammation-B6 bidirectional relationship is replicated across large studies, and the Ghavidel-Parsa 2022 fibromyalgia RCT is the kind of direct clinical evidence I find genuinely compelling. The safety story is also complete enough to tell honestly: standard doses are well within the safe range; the neuropathy ceiling at chronic megadoses is real and documented. That combination of evidence clarity and honest safety picture is what I look for when I evaluate whether an ingredient belongs in this formula.*
— Cristina
* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
— Cristina Lanzieri, EVP of Sales & Marketing
EVP of Sales & Marketing
Cristina Lanzieri is the next generation of the family company. She joined LanFam Health to bridge the founders' lived experience and pharmaceutical depth with how a modern audience actually finds, evaluates, and uses health products today. She runs Sales and Marketing, but her content identity is broader — she's the voice for everything that pulls the LanFam mission forward.
Where her father Fabio writes about mechanism and her mother Maria writes about life-on-the-other-side, Cristina writes about what's next: recovery programs, cervical wellness, daily function, and the under-50 angle on supplementation.
What Cristina writes about
- Cervical wellness and recovery programs
- The under-50 lens on chronic inflammation and supplementation
- Daily function and consistency — the part of wellness that's about showing up
- Modern wellness landscape — what's hype, what's signal, what's worth attention
- The forward-looking side of the LanFam mission
There's a seat at our table
Letters from our family to yours — the science, the recipes, the things that actually helped real families. Leave your email and we'll send the next one.
